ArticleFrontiers in immunology2022

Novel Synthetic Lipopeptides as Potential Mucosal Adjuvants Enhanced SARS-CoV-2 rRBD-Induced Immune Response.

Ling Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.